On Nov 05, major Wall Street analysts update their ratings for $Revvity (RVTY.US)$, with price targets ranging from $132 to $145.
Barclays analyst Luke Sergott maintains with a buy rating, and maintains the target price at $140.
Evercore analyst Vijay Kumar maintains with a buy rating, and adjusts the target price from $132 to $134.
TD Cowen analyst Daniel Brennan maintains with a buy rating, and adjusts the target price from $141 to $144.
Baird analyst Catherine Ramsey Schulte maintains with a buy rating, and adjusts the target price from $136 to $138.
KeyBanc analyst Paul Knight maintains with a buy rating, and adjusts the target price from $126 to $132.
Furthermore, according to the comprehensive report, the opinions of $Revvity (RVTY.US)$'s main analysts recently are as follows:
The firm noted that the primary area of weakness for Revvity in the third quarter was in instruments, with management adjusting the fourth quarter guidance to indicate that this trend is persisting.
Revvity reported third-quarter revenue and EPS that surpassed the consensus, displaying varied revenue performance. The company has conveyed a sense of steadiness within the pharmaceutical and biotech sectors, but has noted that spending on instruments by customers is still restricted, especially in China.
Here are the latest investment ratings and price targets for $Revvity (RVTY.US)$ from 6 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.